Key result
Lifestyle modifications and SGLT2 inhibitors reduce sudden cardiac death risk in type 2 diabetes.
Why the study?
Do lifestyle modifications and medications reduce sudden cardiac death in patients with type 2 diabetes?
Design
Systematic review
Authors
Loading...
Supports SGLT2 inhibitor use and lifestyle interventions in type 2 diabetes to reduce sudden cardiac death; extends prior cardiovascular outcome data to this endpoint.
Systematic Review
Do lifestyle modifications and medications reduce sudden cardiac death in patients with type 2 diabetes?
This systematic review highlights the pathophysiological link between type 2 diabetes and sudden cardiac death, emphasizing the role of lifestyle modifications and SGLT2 inhibitors in risk reduction.
Singh et al. (2021) conducted a systematic review in Type 2 diabetes and sudden cardiac death. Lifestyle modification and medications (e.g., SGLT2 inhibitors) was evaluated. Type 2 diabetes is a significant modifiable risk factor for sudden cardiac death, and prevention measures including lifestyle modifications and SGLT2 inhibitors can help lower this risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: